The use of cinnamon oil as antibacterial agent to eliminate some antibiotic-resistant bacteria isolated from water sources

Abstract

Article Details: Received: 2020-07-09 | Accepted: 2020-10-14 | Available online: 2021-03-31 https://doi.org/10.15414/afz.2021.24.01.1-8

Extended-spectrum β-lactamases (ESBL) are enzymes produced by Gram-negative microorganisms, which may be resistant to commonly used antibiotics. The purpose of this research was to estimate the bactericidal effects of cinnamon oil on ESBLproducing bacteria. In this study, 227 water samples were collected from wells in Hafr Al-Batin, Saudi Arabia. The samples were cultured on a cystine lactose electrolyte-deficient (CLED) medium. A MicroScan system was used to identify bacteria and also for antimicrobial susceptibility test. Activity of crud cinnamon oil and its fractions were detected by determining the minimum inhibitory concentration (MIC) against the ESBL-producing bacteria. Morphological changes of the treated bacteria were observed and oil compounds was investigated. The culture was positive on the CLED medium in 170 out of 227 water samples. In 170 CLED-positive isolates, E. coli was the most common organism, followed by K. pneumoniae. The results showed that 100% of K. pneumoniae isolates were completely resistant to ampicillin (100%), then by mezlocillin (92.5%), cefazolin, and cefuroxime (77.5%). Also, 86.9% of E. coli isolates were the most resistant to ampicillin, followed by mezlocillin (83%). 82% of K. pneumoniae and 89% of E. coli isolates were confirmed by phenotypic confirmatory disc diffusion test (PCDDT) as ESBL-producers. The cinnamon oil activity was only concentrated in the oxygenated fraction. The MICs of the oxygenated fraction were 80 and 20 µl/mL at 105 CFU of ESBL-producing E. coli and K. pneumoniae, respectively. This study indicated the antibacterial effects of cinnamon essential oil to eliminate some antibiotic-resistant bacteria from water.

Keywords: water, Escherichia coli, Klebsiella pneumoniae, antibiotic resistance, essential oil

References

ADEYEMI, A.O. et al. (2014). Antibiotics susceptibility patterns of some uropathogens to nitrofurantoin and nalidixic acid among pregnant women with urinary tract infections in federal medical centre, Bida, Niger-State, North Central, Nigeria. American Journal of Epidemiology and Infectious Disease, 2, 88–92. http://dx.doi.org/10.12691/ajeid-2-4-1

AL YOUSEF, S. A. et al. (2016). Control. Detection of extended spectrum beta-lactamase producing Escherichia coli on water at Hafr Al Batin, Saudi Arabia. Journal of Pollution Effects & Control, 4(01). http://dx.doi.org/10.4172/2375-4397.1000155

BRADFORD, P.A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews, 14(4), 933–951. http://dx.doi.org/10.1128/cmr.14.4.933-951.2001

BRENES, A. and ROURA, E. (2010). Essential oils in poultry nutrition: Main effects and modes of action. Animal Feed Science and Technology, 158, 1–14. http://dx.doi.org/10.1016/j.anifeedsci.2010.03.007

BURT, S. (2004). Essential oils: their antibacterial properties and potential applications in foods – a review. International Journal of Food Microbiology, 94(2), 223–253. http://dx.doi.org/10.1016/j.ijfoodmicro.2004.03.022

CHANG, C.W. et al. (2008). Antibacterial activities of plant essential oils against Legionella pneumophila. Water Research, 42, 278–286. http://dx.doi.org/10.1016/j.watres.2007.07.008

DIAO, W.R. et al. (2013). Chemical composition and antibacterial activity of the essential oil from green huajiao (Zanthoxylum schinifolium) against selected foodborne pathogens. J. Agric. Food Chem., 61(25), 6044–6049. http://dx.doi.org/10.1021/jf4007856

DOI, Y. et al. (2007). Community-acquired extended-spectrum β-lactamase producers, United States. Emerging Infectious Diseases, Centers for Disease Control and Prevention (CDC), 13(7),1121–1123. http://dx.doi.org/10.3201/eid1307.070094

DORMAN, H. and DEANS, S.G. (2000). Antimicrobial agents from plants: antibacterial activity of plant volatile oils. Journal of Applied Microbiology, 88(2), 308–416. http://dx.doi.org/10.1046/j.1365-2672.2000.00969.x

GASPARI, R.J. et al. (2005). Antibiotic resistance trends in paediatric uropathogens. International Journal of Antimicrobial Agents, 26(4), 267–271. https://doi.org/10.1016/j.ijantimicag.2005.07.009

JONES R.N. (1986). NCCLS standards: approved methods for dilution antimicrobial susceptibility tests. Antimicrobic Newsletter, 3(1), 1–3. http://dx.doi.org/10.1016/0738-1751(86)90022-5

KOHANSKI, M.A. et al. (2007). A common mechanism of cellular death induced by bactericidal antibiotics. Cell, 130(5), 797–810. http://dx.doi.org/10.1016/j.cell.2007.06.049

LAL, P. et al. (2007). Occurrence of TEM & SHV gene in extended spectrum β-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J. Med. Res., 125, 173–178.

LIN, L. et al. (2017). Antibacterial poly (ethylene oxide) electrospun nanofibers containing cinnamon essential oil/ beta-cyclodextrin proteoliposomes. Carbohydrate Polymers, 178, 131–140. http://dx.doi.org/10.1016/j.carbpol.2017.09.043

MAcKENZIE, F. et al. (2002). Comparison of screening methods for TEM-and SHV-derived extended-spectrum β-lactamase detection. Clinical Microbiology and Infection, 8(11), 715–724. http://dx.doi.org/10.1046/j.1469-0691.2002.00473.x

MOLAND, E.S et al. (2002). Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 US hospitals. 2002. American Society for Microbiology, 46(12), 3837–3842. http://dx.doi.org/10.1128/aac.46.12.3837-3842.2002

NARAYANASWAMY, A. and MALLIKA M.E. (2011). Prevalence and Susceptibility of extended spectrum beta-lactamases in urinary isolates of Escherichia coli in a Tertiary Care Hospital, Chennai-South India. Internet Journal of Medical Update, 6(1), 39–43. http://dx.doi.org/10.4314/ijmu.v6i1.63975

OJAGH, S.M. et al. (2010). Development and evaluation of a novel biodegradable film made from chitosan and cinnamon essential oil with low affinity toward water. Food Chemistry, 122(1), 161–166. http://dx.doi.org/10.1016/j.foodchem.2010.02.033

PATEL, J. et al. (2001). M100-S25, Performance standards for antimicrobial susceptibility testing. Clinical Microbiology Newsletter, 23, 35–49. http://dx.doi.org/10.1016/s0196-4399(01)88009-0

PESAVENTO, G. et al. (2015). Antibacterial activity of Oregano, Rosmarinus and Thymus essential oils against Staphylococcus aureus and Listeria monocytogenes in beef meatballs. Food Control, 54, 188–199. http://dx.doi.org/10.1016/j.foodcont.2015.01.045

RAEISI, M. et al. (2015). Antimicrobial effect of cinnamon essential oil against Escherichia coli and Staphylococcus aureus. Health Scope, 4(4), e21808. http://dx.doi.org/10.17795/jhealthscope-21808

RAMESH, N. et al. (2019). Extended Spectrum Beta-lactamase (ESBL)-mediated resistance to third generation cephalosporins and conjugative transfer of resistance in Gram-negative bacteria isolated from hospitals in Tamil Nadu, India. Preprints, 2019100103. http://dx.doi.org/10.20944/preprints201910.0103.v1

REDDY, N. and YANG, Y. (2015). Coconut Husk Fibers, Natural Cellulose Fibers from Renewable Resources. In Innovative Biofibers from Renewable Resources, 24, 31–34.

RODRIGUES, C. et al. (2004). Detection of-lactamases in nosocomial gram negative clinical isolates. Indian J. Med. Microbiol, 22, 247–250.

ROSENTHAL, V.D. et al. (2010). International nosocomial infection control consortium (INICC) report, data summary for 2003–2008, issued June 2009–2010. American Journal of Infection Control, 38(2), 95–104. http://dx.doi.org/10.1016/j.ajic.2009.12.004

SHAABAN, H.A. et al. (2012). Bioactivity of essential oils and their volatile aroma components. Journal of Essential Oil Research, 24(2), 203–212. http://dx.doi.org/10.1080/10412905.2012.659528

SHAKIBAIE, M.R. et al. (2014). Antimicrobial susceptibility pattern and ESBL production among uropathogenic Escherichia coli isolated from UTI children in pediatric unit of a hospital in Kerman, Iran. British Microbiology Research Journal, 4(3), 262– 271. http://dx.doi.org/10.9734/bmrj/2014/6563

STURENBURG, E. and Mack, D.J. (2003). Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. Journal of Infection, 47(4), 273–395. https://doi.org/10.1016/S0163-4453(03)00096-3

ZORC, J.J. et al. (2005). Diagnosis and management of pediatric urinary tract infections. Clinical Microbiology Reviews, 18(2), 417–422. http://dx.doi.org/10.1128/cmr.18.2.417-422.2005